Newsroom

TORONTO--(BUSINESS WIRE)--ClearScore launches pre-approval in Canada, showing users eligible loans and credit cards to avoid declines and simplify financial decisions....

LUXEMBOURG--(BUSINESS WIRE)--SES, a leading space solutions company, and PGA TOUR Studios announced today a new agreement to provide tournament content delivery and orchestration with SES’s hybrid IP, fiber and satellite network and the unique Sports Content Orchestration Enabler (SES SCORE) platform. PGA TOUR Studios will utilize SES’s leading end-to-end sports technology and hybrid infrastructure to deliver over 5,000 hours of content annually worldwide. This includes content coordination, mo...

DUBLIN--(BUSINESS WIRE)--The "Vertigo Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Vertigo Drugs Market is projected to grow significantly, with a valuation of USD 1.66 billion in 2025 and targeted to reach USD 2.38 billion by 2034 at a CAGR of 3.9%. This market covers the pharmacologic management of various vestibular disorders within multiple medical settings, including ENT, neurology, and primary care. Core applic...

ABERDEEN, Scotland--(BUSINESS WIRE)--KNOT Offshore Partners LP (NYSE:KNOP) (“The Partnership”) today announced that, due to a lack of quorum, it has adjourned its 2025 Annual Meeting of limited partners until 3 P.M. UK time on December 22, 2025, at Floor 19, 1 Cabot Square, Canary Wharf, London E14 4QJ, United Kingdom. The record date for voting at the Annual Meeting will remain November 6, 2025. No changes have been made in the proposals to be voted on by unitholders at the Annual Meeting. The...

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to three classes of notes issued by Monroe Capital ABS Funding III, LP (“MCAF III”), a securitization backed by a portfolio of recurring revenue and middle market corporate loans. MCAF III is a $485.0 million securitization managed by Monroe BDC Advisors, LLC (“Monroe” or the “Collateral Manager”), an affiliate of Monroe Capital LLC. The securitization consists of $310.4 million of Class A notes, $53.35 million of Class B notes, $24.25...

DALLAS--(BUSINESS WIRE)--The Intermediate Court of Appeals of West Virginia has upheld a reduction in assessed value for a set of natural gas liquids pipelines, marking a significant legal validation of KE Andrews’ technical approach to economic obsolescence. The decision reinforces the firm’s long-standing reputation for delivering data-driven, defensible valuations in complex property tax matters. At issue was whether the pipelines, which were operating significantly below design capacity, sh...

MALVERN, Pa.--(BUSINESS WIRE)--The Black Insurance Industry Collective (BIIC) has released its landmark research report, Fostering Black Leadership in Insurance....

NEWARK, N.J.--(BUSINESS WIRE)--Prudential Financial, Inc. (NYSE: PRU) today announced the launch of FlexGuard 2.0, the next evolution of the company’s flagship retail registered index-linked annuity (RILA) U.S. retirement product lineup. Prudential FlexGuard 2.0® registered index-linked annuity builds on the record success* of Prudential’s premier RILA suite with new enhancements driven directly by customer and financial professional input, while maintaining the solution’s customizable protecti...

SANTA CLARA, Calif.--(BUSINESS WIRE)--DoiT, provider of enterprise-grade FinOps and CloudOps solutions, today announced that it has earned the Amazon Web Services (AWS) Managed Services Provider (MSP) Program Designation. This recognition places DoiT among the top tier of AWS MSP Partners worldwide and validates DoiT’s commitment to delivering modern, platform-driven cloud services that accelerate customer innovation, efficiency and cost optimization. AWS is evolving its MSP Program to reflect...

DUBLIN--(BUSINESS WIRE)--The "Spasticity Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The global Spasticity Treatment Market, valued at USD 5.02 billion in 2025, is set to expand at a CAGR of 5.5%, reaching USD 8.13 billion by 2034. This growth is driven by innovations in pharmacologic therapies, interventional procedures, and multimodal rehabilitative modalities designed to manage spasticity associated with various...